These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11261119)

  • 21. [In cases of familial ovarian cancer, always consider the risk of breast cancer].
    Kets CM; Niermeijer MF; Massuger LF; Hoogerbrugge N
    Ned Tijdschr Geneeskd; 2004 Aug; 148(35):1709-11. PubMed ID: 15468897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening.
    Hoskins KF; Zwaagstra A; Ranz M
    Cancer; 2006 Oct; 107(8):1769-76. PubMed ID: 16967460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Awareness of genetic testing for breast cancer risk among women with a family history of breast cancer: effect of women's information sources on their awareness.
    Meischke H; Bowen D; Kuniyuki A
    Cancer Detect Prev; 2001; 25(4):319-27. PubMed ID: 11531008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
    van Dijk S; Timmermans DR; Meijers-Heijboer H; Tibben A; van Asperen CJ; Otten W
    J Clin Oncol; 2006 Aug; 24(22):3672-7. PubMed ID: 16877736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hard choices when breast cancer threatens.
    Mayes JR
    JAAPA; 2001 Mar; 14(3):6, 9. PubMed ID: 11523187
    [No Abstract]   [Full Text] [Related]  

  • 26. BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
    Ratajska M; Brozek I; Senkus-Konefka E; Jassem J; Stepnowska M; Palomba G; Pisano M; Casula M; Palmieri G; Borg A; Limon J
    Oncol Rep; 2008 Jan; 19(1):263-8. PubMed ID: 18097605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of genetic testing for cancer susceptibility in gynecologic practice.
    Karlan BY; Berchuck A; Mutch D
    Obstet Gynecol; 2007 Jul; 110(1):155-67. PubMed ID: 17601911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Family history of breast cancer.
    Lucassen A; Watson E
    BMJ; 2005 Jan; 330(7481):26. PubMed ID: 15626802
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sequence analysis of BRCA1 gene in young breast cancer patients and/or positive family history].
    Hampl M; Plaschke J; Burgemeister R; Schwarz P; Saeger HD; Schackert HK
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):267-72. PubMed ID: 14518257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients.
    Wárlám-Rodenhuis CC; Koot VC; van der Luijt RB; Vasen HF; Ausems MG
    Eur J Cancer; 2005 Jul; 41(10):1409-15. PubMed ID: 15955690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Susceptibility genes of familial breast cancer in Finland].
    Nevanlinna H; Kallioniemi OP
    Duodecim; 1999; 115(21):2365-74. PubMed ID: 11973868
    [No Abstract]   [Full Text] [Related]  

  • 32. Optimal selection of individuals for BRCA mutation testing.
    Evans DG; Lalloo F; Eccles D
    J Clin Oncol; 2006 Jul; 24(20):3311; author reply 3311-2. PubMed ID: 16829657
    [No Abstract]   [Full Text] [Related]  

  • 33. A novel BRCA1 mutation in an Indian family with hereditary breast/ovarian cancer.
    Gajalakshmi P; Natarajan TG; Selvi Rani D; Thangaraj K
    Breast Cancer Res Treat; 2007 Jan; 101(1):3-6. PubMed ID: 17131039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation.
    Metcalfe KA; Foulkes WD; Kim-Sing C; Ainsworth P; Rosen B; Armel S; Poll A; Eisen A; Gilchrist D; Chudley A; Ghadirian P; Maugard C; Lemire EG; Sun P; Narod SA
    Clin Genet; 2008 May; 73(5):474-9. PubMed ID: 18341607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparisons of two breast cancer risk estimates in women with a family history of breast cancer.
    McTiernan A; Kuniyuki A; Yasui Y; Bowen D; Burke W; Culver JB; Anderson R; Durfy S
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):333-8. PubMed ID: 11319173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients.
    Choi DH; Lee MH; Bale AE; Carter D; Haffty BG
    J Clin Oncol; 2004 May; 22(9):1638-45. PubMed ID: 15117986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer screening for Korean women must consider traditional risks as well as two genetic risk factors: genetic polymorphisms and inheritable gene mutations.
    Anderson G; Jun M; Choi K
    Cancer Nurs; 2007; 30(3):213-22. PubMed ID: 17510585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathological criteria and selection algorithms for BRCA1 genetic testing.
    Gadzicki D; Schubert A; Fischer C; Milde S; Lehmann U; Steinemann D; Lück HJ; Kreipe H; Schlegelberger B
    Cancer Genet Cytogenet; 2009 Mar; 189(2):105-11. PubMed ID: 19215791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic testing for familial cancer. The French National Report (year 2003).
    Eisinger F
    Community Genet; 2008; 11(1):63-7. PubMed ID: 18196919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.